NCT01044771View on ClinicalTrials.gov

Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

June 30, 2011

Conditions
HIV InfectionsProteinuria
Interventions
DRUG

change from tenofovir to raltegravir

Change of the tenofovir based nucleoside part of the HIV regimen to raltegravir, 400mg BID

Sponsors

Lead Sponsor

Metropolis Medical
All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Metropolis Medical

OTHER

NCT01044771 - Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria | Biotech Hunter | Biotech Hunter